Literature DB >> 21478871

CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation.

David M Burns1, Andrea D'Ambrogio, Stephanie Nottrott, Joel D Richter.   

Abstract

Cytoplasmic polyadenylation-induced translation controls germ cell development, neuronal synaptic plasticity and cellular senescence, a tumour-suppressor mechanism that limits the replicative lifespan of cells. The cytoplasmic polyadenylation element binding protein (CPEB) promotes polyadenylation by nucleating a group of factors including defective in germline development 2 (Gld2), a non-canonical poly(A) polymerase, on specific messenger RNA (mRNA) 3' untranslated regions (UTRs). Because CPEB regulation of p53 mRNA polyadenylation/translation is necessary for cellular senescence in primary human diploid fibroblasts, we surmised that Gld2 would be the enzyme responsible for poly(A) addition. Here we show that depletion of Gld2 surprisingly promotes rather than inhibits p53 mRNA polyadenylation/translation, induces premature senescence and enhances the stability of CPEB mRNA. The CPEB 3' UTR contains two miR-122 binding sites, which when deleted, elevate mRNA translation, as does an antagomir of miR-122. Although miR-122 is thought to be liver specific, it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-canonical poly(A) polymerase, was found to regulate p53 mRNA polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4. ©2011 Macmillan Publishers Limited. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478871      PMCID: PMC3088779          DOI: 10.1038/nature09908

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


Mouse embryo fibroblasts (MEFs) derived from CPEB knockout (KO) mice do not senesce as do MEFs derived from wild type (WT) mice, but instead are immortal. Senescence is rescued when ectopic CPEB is expressed in the KO MEFs and potentiated when expressed in WT MEFs7. Human foreskin fibroblasts depleted of CPEB also bypass senescence and divide ~270 days compared to WT cells, which senesce after about 90 days. As with the mouse cells, ectopic expression of CPEB rescues senescence in knockdown cells and potentiates senescence in WT cells. CPEB controls the polyadenylation-induced translation of p53 mRNA, and indeed CPEB-induced senescence requires p53. Depletion of CPEB also induces the “Warburg Effect” where mitochondrial respiration is reduced and cells produce ATP primarily through glycolysis6. To investigate the possibility that CPEB control of p53 polyadenylation requires Gld2, human primary foreskin fibroblasts were stably transduced with lentiviruses expressing two different shRNAs against the Gld2 coding sequence. Surprisingly, Gld2 depletion (Fig. 1a, 1b) induced an increase in both p53 protein levels (Fig. 1c) and p53 mRNA polyadenylation (Fig. 1d; Supplemental Fig. 1). Also unexpectedly, depletion of Gld2 resulted in increased oxygen consumption (Fig. 1e) and entry into a senescence-like cell cycle arrest as evidenced by ß-galactosidase staining at acid pH (Fig. 1f). In comparison, CPEB depleted cells had decreased oxygen consumption, fewer cells staining with ß-galactosidase, increased lifespan, and most importantly, reduced poly(A) tail size on p53 mRNA and ~50% reduction in p53 protein levels6.
Figure 1

Depletion of Gld2 enhances p53 expression. (a) RT-PCR of Gld2 and tubulin RNAs following infection of human foreskin fibroblasts with lentiviruses expressing shRNA against Gld2 or GFP (mock, same in all panels). (b) Knockdown of Gld2-HA in cells expressing ectopic Gld2-HA. Tubulin served as a loading control. (c) Western blot showing 2.5 fold enhanced expression of p53 relative to tubulin following Gld2 depletion. (d) Poly(A) tail analysis of p53 mRNA in WT and Gld2 depleted cells (two shRNAs targeting different regions of Gld2 were used). (e) Oxygen consumption in cells infected with shCPEB, shGld2, or empty vector (Mock). (f) Mock or shGld2 infected cells stained for ß-galactosidase, which denotes cellular senescence. Population doublings were determined in wild type or Gld2 depleted cells.

These paradoxical results prompted us to examine CPEB levels in Gld2 deficient cells since CPEB is required for normal p53 mRNA translation6. After comparing the amounts of CPEB nuclear pre-mRNA by intron-specific quantitative RT-PCR and mostly cytoplasmic mRNA by exon-specific quantitative RT-PCR, we found that the pre-mRNA levels, which generally reflect transcription, were nearly unchanged while cytoplasmic mRNA levels increased by about five-fold (Fig. 2a). Thus, in the absence of Gld2, CPEB mRNA unexpectedly was more stable.
Figure 2

Gld2 knockdown increases CPEB reporter mRNA and translation by a post-transcriptional mechanism. (a) Fold change of nuclear (intron-containing) or predominantly cytoplasmic (exon-containing) CPEB RNA following Gld2 depletion (n=3, bars are s.e.m.) (b) Schematic of reporter constructs used in the following experiments (numbers refer to nucleotides of CPEB 3’UTR). (c and d) Cells expressing firefly luciferase (Fluc) as a control and Renilla luciferase (Rluc) as noted in panel b were depleted of Gld2; the amount of Renilla lucifease activity (relative to firefly) was derived from RNA containing the entire CPEB 3’UTR (full) and set at 100. In all panels, n = 3 and the bars refer to s.e.m.; one or two asterisks refer to statistical significance (Students t test) at the p<0.05 or p<0.01 levels, respectively.

Surmising that Gld2 might control p53 protein levels via CPEB, we next used a Renilla luciferase (Rluc) and firefly luciferase (Fluc) reporter system to investigate post-transcriptional regulation of CPEB by Gld2. As shown in Figs. 2b and 2c, the entire CPEB 3’ UTR was translated about 40% less efficiently compared to a reporter lacking the 3’ most 455 nucleotides (Mock). However, in Gld2-deficient cells, the two reporters were translated equally. Additional deletions (Δ) of the CPEB 3’ UTR suggested that there might be multiple regions that elicited increases in reporter translation following Gld2 knockdown (i.e., ΔE translation was about two fold greater than ΔB, ΔC, or ΔD translation) (Fig. 2d). Analysis of the regions of the CPEB 3’ UTR that mediated translational repression by Gld2 revealed the presence of two potential miR-122 binding sites (Supplementary Fig. 2). Although miR-122 is thought to be liver-specific and account for ~70% of the total population of microRNAs in that tissue13, deletion of these specific sites, either individually or combined, alleviated translational repression in Gld2 depleted cells (Fig. 3a) and were nearly identical to that observed with the large deletions (Fig. 2d). These results suggest that miR-122 might repress CPEB mRNA translation in human skin fibroblasts and indicate that this miRNA is more widely distributed than originally thought. Indeed recent evidence shows that miR-122 is present in human skin14 and even HEK293 cells15.
Figure 3

miR-122 activates p53 mRNA translation by repressing CPEB. (a) Gld2 depleted fibroblasts were transduced with firefly and Renilla luciferase with CPEB full length or deletion mutant 3’UTRs lacking putative miR-122 sites (Supplementary Fig. 2). The data are expressed as in Fig 2; in all panels, n = 3 and the bars refer to s.e.m. and one or two asterisks refer to statistical significance (Students t test) at the p<0.05 or p<0.01 levels, respectively. (b) Sequence of miR-122 from fibroblasts; a non-templated adenosine is shaded. (c) Fibroblasts expressing firefly and Renilla luciferase containing the CPEB 3’ UTR were electroporated with miR-122 (Anta-122), scrambled, (Anta-Scr), or no LNA antagomir (Mock); data are expressed as in Figure 2. (d) Quantitative RTPCR for miR-122 in cells expressing GFP (WT) or shGld2. (e and f) Immunoprecipitation of 35S-methonine-labeled p53 from MG132-treated cells transduced with no (Mock-GFP), miR-122 (Anta-122), or scrambled (Anta-Scram) LNA antagomirs. WCE refers to whole cell lysate. (g) Fibroblasts were treated as in panels e-g after first expressing either TET repressor (shTETR, a control) or CPEB shRNA.

To assess directly whether miR-122 might repress CPEB mRNA expression, we first cloned and sequenced it from human foreskin fibroblasts and found that it contained a nontemplated 3’ monoadenylate residue (Fig. 3b; see discussion). Next, cells were electroporated with a locked nucleic acid (LNA) antagomir for miR-122, or as a control, a scrambled LNA. The miR-122 antagomir enhanced reporter expression by about 3.25 fold relative to control (Fig. 3c), but had no stimulatory effect on a reporter whose 3’ UTR contained no miR-122 sites (Supplementary Fig. 3). Based on evidence from Katoh et al16, who demonstrated that in murine liver, Gld2 is essential for miR-122 stability, we suspected that Gld2 might influence CPEB expression and possibly p53 mRNA translation by controlling miR-122 steady-state levels. Indeed, Fig. 3d demonstrates that depletion of Gld2 from skin fibroblasts reduced the level of miR-122 by nearly 40-fold. Importantly, when miR-122 LNA antagomir-transduced cells were incubated with the proteasome inhibitor MG132 and pulsed-labeled with 35S-methionine for 15 min followed by p53 immunoprecipitation, there was a two-fold increase in the synthesis rate of p53 (Fig. 3e, 3f). Taken together, these data demonstrate that human primary skin fibroblasts contain miR-122 and that Gld2 controls its steady state levels or activity. While consistent with the hypothesis that miR-122 mediates p53 mRNA translation via CPEB, these data do not eliminate the possibility that miR-122 could act via another molecule to regulate p53 synthesis (note that p53 mRNA has no miR-122 sites according to Targetscan.org or Microrna.org). Consequently, we infected cells with a lentivirus expressing shRNA for CPEB as well as the miR-122 antagomir followed by a 15 minute pulse of 35S-methionine and p53 immunoprecipitation. Fig. 3g shows that although miR-122 antagomir alone elicited an increase in p53 synthesis, the antagomir plus shRNA for CPEB induced no increase. Taken together, these data demonstrate that Gld2 activity stabilizes miR-122, which in turn reduces CPEB expression; CPEB then acts directly on p53 mRNA to control poly(A) tail length and translation. If not Gld2, what poly(A) polymerase modifies p53 mRNA polyadenylation and translation? We surmised that an alternative non-canonical poly(A) polymerase, i.e., one that lacks an RNA binding domain and thus would require another factor such as CPEB to be tethered to the RNA, would most likely be involved. Two cytoplasmic enzymes have this characteristic: Gld4 (PAPD5)17 and MitoPAP (PAPD1)18. Both polymerases were depleted with shRNAs (Supplementary Fig. 4) but only the loss of Gld4 reduced p53 protein levels (Fig. 4a). To investigate whether Gld4 interacts with p53 mRNA in a CPEB-dependent manner, FLAG-Gld4 was expressed in cells (Supplementary Fig. 5) containing shRNA for tetracycline repressor (TETR, a control) or CPEB. Gld4 was then immunoprecipitated and the extracted RNA was examined for p53 and GAPDH (a control) RNAs by RT-PCR (Fig. 4b). p53 mRNA was detected only when CPEB was present, suggesting that Gld4 is anchored to p53 mRNA by CPEB, and indeed, CPEB co-immunoprecipitated Gld4 but not Mcl1, a nonspecific control (Fig. 4c). Finally, depletion of Gld4 reduced p53 mRNA polyadenylation (Fig. 4d), which probably then induced p53 mRNA destabilization (Fig. 4e; depletion of Gld4 reduced mostly cytoplasmic p53 mRNA as examined by RT-PCR using exon-specific primers but had no effect on p53 transcription as examined by RT-PCR using intron-specific primers).
Figure 4

Gld4 controls p53 mRNA expression. (a) p53 and actin western blots from fibroblasts expressing GFP (mock), shGld4, or shMitoPAP (shMPAP). (b) Fibroblasts containing shTETR or CPEB were transfected with Gld4-FLAG followed by FLAG antibody or IgG immunoprecipitation of RNA complexes and RT-PCR for p53 or GAPDH (control) RNAs. (c) Protein from fibroblasts infected with Gld4-HA and CPEB-FLAG was FLAG or IgG immunoprecipitated and western blotted for HA. Other cells infected with CPEB-FLAG and MCl1-HA (a nonspecific control) were processed similarly. (d) Examination of p53 poly(A) tail6 from skin fibroblasts expressing GFP or (mock) Gld4 or mitoPAP shRNAs. (e) RT-PCR analysis of predominantly cytoplasmic p53 RNA (exon-specific primers), or nuclear p53 pre-mRNA (intron-specific primers) in cells expressing GFP (mock) or Gld4 or MitoPAP shRNAs. (f) Model for regulation of p53 translation; see text for explanation.

The results presented here and in Katoh et al. (ref. 16) suggest a model for homeostatic control of p53 synthesis in human skin fibroblasts (Fig. 4f). Gld2 stabilizes miR-122 by catalyzing the addition of a single adenylate residue to its 3’ end16. miR-122 then base-pairs to two regions of the CPEB 3’ UTR, causing instability and/or translational inhibition of the mRNA. CPEB, whose levels are modulated by these events, binds to the p53 3’UTR and recruits Gld4, which in turn maintains p53 mRNA polyadenylation and translation. We envision this hierarchical regulation of p53 to resemble a rheostat, where translation is turned up or down rather than a switch, where translation is turned on or off19, although p53 mRNA translation can also be controlled by a switch mechanism in response to DNA damage20,21. A 50% change in p53 synthesis can toggle a cell between growth and senescence6, demonstrating that drastic biological consequences result from a relatively modest change in protein level. Although ectopically-expressed Gld2 immunoprecipitated from hepatocarcinoma cells adds a single adenosine to miR-122 in vitro16, Gld2 tethered to a small non-coding RNA by MS2 adds >300 adenylate residues in injected oocytes22, and about that same amount to mRNA when bound to CPEB10. How the enzyme can modulate its catalytic activity depending on the substrate is unknown, but we postulate that components of the RNA-induced silencing complex (RISC) might be responsible. In addition to our demonstration that miR-122 is 3’ mono-adenylated in skin fibroblasts, ~20% of all RNA deep sequencing reads from cloned neuroblastoma miRNAs contain a non-templated adenylate residue23, suggesting that miR-122 may be one of several miRNAs that are mono-adenylated by Gld2. In conclusion, our results demonstrate that Gld2 control of miR-122 stability in human skin fibroblasts tunes CPEB expression, which in turn regulates p53 mRNA polyadenylation and translation by Gld4. The coordinated activities of these factors then gate entry into senescence. These studies also bring up two additional aspects of CPEB-related activities: how does Gld4, but not Gld2, associate with CPEB on p53 mRNA, and what molecular machinery is responsible for miR-122 destruction upon Gld2 depletion? Deciphering the mechanisms involved would likely require analysis of the combinatorial associations of factors on different RNA substrates.

METHODS SUMMARY

Molecular biology and cell culture

Primary human foreskin fibroblasts obtained from the Cell Culture Core Facility of the Yale University Skin Disease Research Center were cultured as described 24 in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum. Amphotropic retroviruses and shRNA-containing lentiviruses were produced by transient transfection of 293T cells with a transfer vector and amphotropic packaging plasmids encoding VSV-G and gag-pol using Lipofectamine 2000 (Invitrogen). Human cells at 50% confluency were infected for 8-12 hr with viral supernatants containing 7μg/ml polybrene. Typically 70-90% infection efficiency was achieved as assessed by a GFP-encoding viral gene or by immunostaining with HA antibody (Covance). After infection, fresh medium was added to the infected fibroblasts. Some cells were analyzed by western blotting for p53 (DO-1, Neomarkers) and Δ-actin (Abcam). Other cells were fixed with 0.2% glutaraldehyde and stained for Δ-galactosidase activity at acidic pH according to Dimri et al25.
  27 in total

1.  Selective modulation of some forms of schaffer collateral-CA1 synaptic plasticity in mice with a disruption of the CPEB-1 gene.

Authors:  Juan M Alarcon; Rebecca Hodgman; Martin Theis; Yi-Shuian Huang; Eric R Kandel; Joel D Richter
Journal:  Learn Mem       Date:  2004 May-Jun       Impact factor: 2.460

2.  Species- and cell type-specific requirements for cellular transformation.

Authors:  Annapoorni Rangarajan; Sue J Hong; Annie Gifford; Robert A Weinberg
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

3.  CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses.

Authors:  L Wu; D Wells; J Tay; D Mendis; M A Abbott; A Barnitt; E Quinlan; A Heynen; J R Fallon; J D Richter
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

4.  Reproducible pattern of microRNA in normal human skin.

Authors:  Line Marie Holst; Bogumil Kaczkowski; Robert Gniadecki
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

5.  Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA.

Authors:  R Mendez; L E Hake; T Andresson; L E Littlepage; J V Ruderman; J D Richter
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

6.  Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin.

Authors:  Masatoshi Takagi; Michael J Absalon; Kevin G McLure; Michael B Kastan
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

7.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

8.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

9.  Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation.

Authors:  Daron C Barnard; Kevin Ryan; James L Manley; Joel D Richter
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

10.  Mammalian GLD-2 homologs are poly(A) polymerases.

Authors:  Jae Eun Kwak; Liaoteng Wang; Scott Ballantyne; Judith Kimble; Marvin Wickens
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

View more
  106 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Authors:  Aldema Sas-Chen; Roi Avraham; Yosef Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-12       Impact factor: 2.673

3.  Transcriptome-wide analysis of small RNA expression in early zebrafish development.

Authors:  Chunyao Wei; Leonidas Salichos; Carli M Wittgrove; Antonis Rokas; James G Patton
Journal:  RNA       Date:  2012-03-08       Impact factor: 4.942

Review 4.  Translational control by changes in poly(A) tail length: recycling mRNAs.

Authors:  Laure Weill; Eulàlia Belloc; Felice-Alessio Bava; Raúl Méndez
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

5.  Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex.

Authors:  Tsuyoshi Udagawa; Sharon A Swanger; Koichi Takeuchi; Jong Heon Kim; Vijayalaxmi Nalavadi; Jihae Shin; Lori J Lorenz; R Suzanne Zukin; Gary J Bassell; Joel D Richter
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

6.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 7.  Translational control in cellular and developmental processes.

Authors:  Jian Kong; Paul Lasko
Journal:  Nat Rev Genet       Date:  2012-06       Impact factor: 53.242

Review 8.  RNA protein interaction in neurons.

Authors:  Robert B Darnell
Journal:  Annu Rev Neurosci       Date:  2013-05-20       Impact factor: 12.449

9.  An unusual two-step control of CPEB destruction by Pin1.

Authors:  Morris Nechama; Chien-Ling Lin; Joel D Richter
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

10.  Translational control of cell growth and malignancy by the CPEBs.

Authors:  Andrea D'Ambrogio; Kentaro Nagaoka; Joel D Richter
Journal:  Nat Rev Cancer       Date:  2013-02-28       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.